Logo
SearchSearch
Languages
Language
LoginSign up
Invest in Intra-Cellular Therapies Inc
Today
Create an eToro account to buy ITCI stock on a secure, user-friendly, multi-asset trading platform.
Buy Intra-Cellular Therapies Inc
Buy Intra-Cellular Therapies Inc
Intra-Cellular Therapies Inc ITCI
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Hold
Price Target
132
Based on analysts who covered ITCI
Stocks-ITCI-Intra-Cellular Therapies Inc

Intra-Cellular Therapies Inc ITCI

$131.24-0.01(-0.01%)(1D)
Nasdaqin USD

ITCI Stock Price Chart

‎3.31‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset positive trend

The Intra-Cellular Therapies Inc share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Intra-Cellular Therapies Inc share price today is $131.24, reflecting a ‎-0.01‎% change over the last 24 hours and ‎2.31‎% over the past week. The current market capitalization of ITCI is 13.95B with an average volume in the last three months of 2.89M. The stock has a P/E ratio of -181.82 and a dividend yield of 0%. With the stock’s beta sitting at 0.67
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$13.95B

Day’s Range
i
Shows the high and low prices of the day.
127.83 - 131.14

52W Range
i
Shows the high and low prices of the last year.
45.4 - 131.14

Average Volume (3M)
i
The average number of shares traded per day over the last three months.
2.89M

Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-181.82

Revenue
i
The total income generated by this company’s goods and services last year.
$680.85M

Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)

Prev Close
i
The final price of this asset at the end of the last trading day.
$131.24

EPS
i
A company’s total earnings divided by the number of shares it has issued.
-0.72

Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
0.67

What Is Intra-Cellular Therapies Inc?
The biopharmaceutical company Intra-Cellular Therapies operates primarily within the US. The company develops novel drugs for treating neurologic and neuropsychiatric diseases, as well as other disorders of the central nervous system. Headquartered in New York, the company was founded in 2002 and uses the ITCI ticker on the NASDAQ GS stock market. Track ITCI share price movements easily using your eToro watchlist.

How can I buy Intra-Cellular Therapies Inc stocks?

To purchase Intra-Cellular Therapies Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Intra-Cellular Therapies Inc (ITCI) page and place an order to buy Intra-Cellular Therapies Inc.
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Graph
Buy Intra-Cellular Therapies Inc
Invest in Intra-Cellular Therapies Inc
Today
Create an eToro account to buy ITCI stock on a secure, user-friendly, multi-asset trading platform.

FAQ

The current price of ITCI is $131.24.
The average price target for Intra-Cellular Therapies Inc is $131.24. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Intra-Cellular Therapies Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Intra-Cellular Therapies Inc is $13.95B
Scroll to top